hotspot -WSS

hotspot

author：fashion 2025-10-02 18:47:47 - browse：84899

translucent 3D DNA helix with blue and purple background — Adobe

Verve Therapeutics said Monday that it had received clearance from the Food and Drug Administration to conduct a clinical trial in the U.S. of its experimental, gene-editing treatment for a common form of heart disease.

The FDA’s action removes a clinical hold on Verve’s CRISPR-based therapy, called VERVE-101, that was placed on it last November. Verve now intends to recruit participants from U.S. sites into a Phase 1 study that’s been underway since last year in New Zealand and the United Kingdom.

“We’re thrilled to get this clearance for VERVE-101,” said Verve CEO Sek Kathiresan. “Our study is called HEART-1 and our plan now is to activate U.S. sites.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： How Medicaid coverage policies for immigrants impact new moms

focus

hotspot

WSS

WATCH: Why do fingernails fall off when they're damaged?

How dance can help nurses traumatized by Covid

A public scorecard can help hold safety

With FDA staff opposed to Sarepta therapy, top official intervened

The science behind Janet Jackson's pregnancy at 49

Death of patient in Alzheimer’s trial raises question of possible risks

hotspot

hotspot

entertainment

Medicare details structure of new drug price negotiation program

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

United colonoscopy coverage change 'may cost lives,' doctors say

How dance can help nurses traumatized by Covid

New air purifier tech could be key to improving indoor air quality

Do masks work? RCTs can't tell us

Medicare details structure of new drug price negotiation program

WHO calls for emergency meeting on new China virus, as cases spread

In age of alternative facts, a scholarly course on calling out crap

3 hurdles to bringing medical devices to the U.S. market

focus

WATCH: Why do fingernails fall off when they're damaged?

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

STAT's guide to the next generation of CAR

Biden tests positive for Covid

Biden tests positive for Covid

Colonoscopy at 40? Study finds a possible benefit

focus

leisure time

hotspot

hotspot